Michael Catalin Vlaicu
Michael Catalin Vlaicu
Send Message
Michael Catalin Vlaicu
Stop FollowingMichael Catalin Vlaicu
View as an RSS Feed
- Why Companies Are Hoarding, Not Hiring
- JPMorgan and Citigroup Earnings Ring Memories of Lehman
- Alcoa's Earnings Beat Was a Sham
-
Discovery Labs: Small Biotech With Multiple Prime Time Catalysts
on Tue, May 11, 2010 • 5 Comments
-
AEterna Zentaris: Uncovering Next Dominant Cancer Company
on Thu, May 6, 2010 • 15 Comments
-
Takeover Speculation Swarms at AspenBio Pharma
on Mon, Apr 26, 2010 • 17 Comments
-
Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps?
on Thu, Apr 22, 2010 • 5 Comments
-
Will Generex Biotech Be Next to Join the Winner's Circle?
on Thu, Jan 21, 2010 • 14 Comments
-
CytRx: Technical Breakout Imminent
on Mon, Nov 23, 2009 • 3 Comments
-
INVO Bioscience: Giving Birth to a Profitable Company
on Sun, Aug 23, 2009 • 9 Comments
- Javelin Pharmaceuticals: Pain for Pleasure
-
Waking Up to Somaxon Pharmaceuticals
on Wed, Jul 22, 2009 • 9 Comments
- Elan Corporation: Shares Seem Undervalued
- TerreStar Corp: Sky High Potential
- Why Access Pharmaceutical's MuGard Will Be Successful
- BioDelivery Sciences: More than a One Drug Company
- Access Pharmaceuticals: Gaining Momentum
- Hemispherx's Ampligen: Fact vs. Fiction
- Hemispherx's Ampligen Also Combats Avian Flu
- Consumer Confidence Index Encourages an Economic Rebound
- Arca Biopharma: Heart Disease Drug Looks Promising
